Enalaprilat
- Strength
- 2.5 mg/2mL
- Form
- Injection
- Class
- Angiotensin Converting Enzyme Inhibitor
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Listed by Dr. Reddys Laboratories Inc
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | Angiotensin Converting Enzyme Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 43598-169 |
| FDA application | ANDA075578 |
| RxNorm concept | 1729200 |
| Package sizes listed | 1 |
| Marketed since | June 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Dr. Reddys Laboratories Inc
Not stocked by us — reference only
HF Acquisition Co LLC, DBA HealthFirst
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.